Organisation paid for research Program year 2024 Source: CMS Open Payments

Womens Ob Gyn PC

Neither a doctor nor a teaching hospital

Research payments

$968,158

118 payments

Through program year 2024, Womens Ob Gyn PC is reported as receiving $968,158 in research payments, across 118 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$22,512	8
2023	Research	$309,104	23
2022	Research	$453,256	38
2021	Research	$166,483	40
2020	Research	$1,750	3
2019	Research	$15,053	6

Breakdown

Who paid Research payments · program years 2019–2024

Abbott Laboratories $888,402 62 payments
Bayer HealthCare Pharmaceuticals Inc. $40,441 39 payments
Astellas Pharma Global Development $22,512 8 payments
AMAG Pharmaceuticals, Inc. $13,325 8 payments
Mitsubishi Tanabe Pharma Development America, Inc. $3,478 1 payment

Studies the money was for Research payments · program years 2019–2024

Alinity m HR HPV Specimen Collection Study from Women Referred to Colposcopy $289,178 24 payments
Alinity m HR HPV Self-Collect Study (CE) Protocol for Specimen Collection from Subjects Undergoing Routine Cervical Cancer Screening $251,808 12 payments
Alinity m HR HPV Specimen Collection Study from Women Undergoing Routine Cervical cancer Screening $114,336 6 payments
Alinity m BV & Alinity m CV/TV Scientific Study Specimen Collection and Testing Protocol $52,496 5 payments
A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms $22,512 8 payments
BAY86-5028 Mirena extension contraception $20,398 17 payments
A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia $11,575 5 payments
BAY1454033 pivotal $7,111 6 payments
BAY1454033, pivotal $6,700 8 payments
Bay1454032 $6,232 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.